Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of Epidural Bupivacaine for Labor Analgesia
NCT05543694Phase 4Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Oct 2022
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in labor pain (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Verbal Numerical Pain Rating Score at 30 months. Started Oct 2022; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT05543694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05543694.